DUISBURG, Germany, Sept. 19, 2025 /PRNewswire/ -- Factor2 Energy, a German (Duisburg) company with a novel approach to geothermal energy, today…
NEW DELHI, Sept. 2, 2025 /PRNewswire/ -- HarperCollins India is delighted to present a new novel by Chetan Bhagat, an irresistible…
ZUG, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to…
Series is Based on New York Times Best Selling Novel and Expands the Popular "True the Game" Franchise Beyond the…
August 21, 2025 01:30 ET | Source: NICOX SA Press Release Nicox Announces Positive Results from the NCX 470 Phase…
August 13, 2025 13:41 ET | Source: Striim, Inc. PALO ALTO, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- With fast…
AHMEDABAD, India, Aug. 5, 2025 /PRNewswire/ -- Intas Pharmaceuticals has launched HETRONIFLY™ (Serplulimab), the first PD-1 inhibitor globally approved for…
Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in…
July 25, 2025 16:15 ET | Source: Portage Biotech Inc. DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech…
– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel long-acting herpes simplex virus helicase-primase…